These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6850578)
21. Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumor growth and invasiveness in a mouse model of multistage cancer. Bell-McGuinn KM; Garfall AL; Bogyo M; Hanahan D; Joyce JA Cancer Res; 2007 Aug; 67(15):7378-85. PubMed ID: 17671208 [TBL] [Abstract][Full Text] [Related]
22. Pepstatin A, an aspartic proteinase inhibitor, suppresses RANKL-induced osteoclast differentiation. Yoshida H; Okamoto K; Iwamoto T; Sakai E; Kanaoka K; Hu JP; Shibata M; Hotokezaka H; Nishishita K; Mizuno A; Kato Y J Biochem; 2006 Mar; 139(3):583-90. PubMed ID: 16567424 [TBL] [Abstract][Full Text] [Related]
23. Cathepsin D is involved in the regulation of transglutaminase 1 and epidermal differentiation. Egberts F; Heinrich M; Jensen JM; Winoto-Morbach S; Pfeiffer S; Wickel M; Schunck M; Steude J; Saftig P; Proksch E; Schütze S J Cell Sci; 2004 May; 117(Pt 11):2295-307. PubMed ID: 15126630 [TBL] [Abstract][Full Text] [Related]
24. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Vasiljeva O; Papazoglou A; Krüger A; Brodoefel H; Korovin M; Deussing J; Augustin N; Nielsen BS; Almholt K; Bogyo M; Peters C; Reinheckel T Cancer Res; 2006 May; 66(10):5242-50. PubMed ID: 16707449 [TBL] [Abstract][Full Text] [Related]
25. [Hydrolysis of synthetic peptides by group D cathepsins]. Kazakova OV; Orekhovich VN Biokhimiia; 1982 Sep; 47(9):1448-53. PubMed ID: 7138961 [TBL] [Abstract][Full Text] [Related]
26. Isolation of procathepsin D from mature cathepsin D by pepstatin affinity chromatography. Autocatalytic proteolysis of the zymogen form of the enzyme. Conner GE Biochem J; 1989 Oct; 263(2):601-4. PubMed ID: 2512908 [TBL] [Abstract][Full Text] [Related]
27. Synthesis of gallic acid based naphthophenone fatty acid amides as cathepsin D inhibitors. Srivastava V; Saxena HO; Shanker K; Kumar JK; Luqman S; Gupta MM; Khanuja SP; Negi AS Bioorg Med Chem Lett; 2006 Sep; 16(17):4603-8. PubMed ID: 16797987 [TBL] [Abstract][Full Text] [Related]
28. Calculating proton uptake/release and binding free energy taking into account ionization and conformation changes induced by protein-inhibitor association: application to plasmepsin, cathepsin D and endothiapepsin-pepstatin complexes. Alexov E Proteins; 2004 Aug; 56(3):572-84. PubMed ID: 15229889 [TBL] [Abstract][Full Text] [Related]
29. Cathepsin D of mouse leukemia L1210 cells. Unusual intracellular localization and biochemical properties. Bowers WE; Beyer CF; Yago N Biochim Biophys Acta; 1977 Mar; 497(1):272-9. PubMed ID: 14706 [TBL] [Abstract][Full Text] [Related]
30. Pepstatin inhibition of cathepsin D in situ and its modification of leukokinin formation: HPLC separation of fluorescamine-treated kinins. Greenbaum LM; Sutherland JH; Narayan TK Adv Exp Med Biol; 1983; 156 (Pt B)():783-7. PubMed ID: 6190383 [No Abstract] [Full Text] [Related]
31. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. Deiss LP; Galinka H; Berissi H; Cohen O; Kimchi A EMBO J; 1996 Aug; 15(15):3861-70. PubMed ID: 8670891 [TBL] [Abstract][Full Text] [Related]
32. Effects of the protease inhibitor leupeptin on proteolytic activities and regeneration of mouse skeletal muscles after exercise injuries. Salminen A Am J Pathol; 1984 Oct; 117(1):64-70. PubMed ID: 6385726 [TBL] [Abstract][Full Text] [Related]
33. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice. Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316 [TBL] [Abstract][Full Text] [Related]
34. Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells. Zang Y; Beard RL; Chandraratna RA; Kang JX Cell Death Differ; 2001 May; 8(5):477-85. PubMed ID: 11423908 [TBL] [Abstract][Full Text] [Related]
35. Receptor-mediated introduction of pepstatin-asialofetuin conjugate into lysosomes of rat hepatocytes. Furuno K; Miwa N; Kato K J Biochem; 1983 Jan; 93(1):249-56. PubMed ID: 6188752 [TBL] [Abstract][Full Text] [Related]
36. Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors. Liaudet E; Derocq D; Rochefort H; Garcia M Cell Growth Differ; 1995 Sep; 6(9):1045-52. PubMed ID: 8519680 [TBL] [Abstract][Full Text] [Related]
37. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing. Moss CX; Villadangos JA; Watts C Eur J Immunol; 2005 Dec; 35(12):3442-51. PubMed ID: 16259009 [TBL] [Abstract][Full Text] [Related]
38. The effects of lactoyl-pepstatin and the pepsin inhibitor peptide on pig cathepsin D. Kay J; Afting EG; Aoyagi T; Dunn BM Biochem J; 1982 Jun; 203(3):795-7. PubMed ID: 7115318 [TBL] [Abstract][Full Text] [Related]
39. Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals. Tessitore L; Costelli P; Bonetti G; Baccino FM Arch Biochem Biophys; 1993 Oct; 306(1):52-8. PubMed ID: 8215420 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of cathepsin D prevents free-radical-induced apoptosis in rat cardiomyocytes. Ollinger K Arch Biochem Biophys; 2000 Jan; 373(2):346-51. PubMed ID: 10620358 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]